Бизнес · 30.05.20251 мин чтения
Meda AB and B. Braun Medical, Inc.; Withdrawal of Approval of Two New Drug Applications
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA or Agency) is withdrawing approval of two new drug applications (NDAs) from two applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.